Anti-HIV activities of novel synthetic peptide conjugated chitosan oligomers

International Journal of Biological Macromolecules

Volumn 66, Issue , 2014, Pages 260-266

  Karagozlu, Mustafa Zafer ^a   Karadeniz, Fatih ^a   Kim, Se Kwon ^a  

^a Pukyong National University   (South Korea)

Author keywords

Chitosan oligomers; HIV; Viral fusion

Indexed keywords

ANTIGEN P24; ANTIVIRUS AGENT; CHITOSAN; GLUTAMYLMETHIONYLTRYPTOPHAN; GLYCOPROTEIN GP 120; GLYCOPROTEIN GP 41; LUCIFERASE; NEVIRAPINE; OLIGOMER; PROTEINASE; RECOMBINANT ENZYME; RNA DIRECTED DNA POLYMERASE; TRIPEPTIDE; TRYPTOPHYLMETHIONYLGLUTAMINE; UNCLASSIFIED DRUG; ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT; PEPTIDE; PEPTIDE HYDROLASE;

ANTIVIRAL ACTIVITY; ARTICLE; CELL ASSAY; CELL PROTECTION; CELL VIABILITY; COCULTURE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN IMMUNODEFICIENCY VIRUS 1; IN VITRO STUDY; MOLECULAR WEIGHT; POLYMERASE CHAIN REACTION; VIRUS CELL INTERACTION; VIRUS ENTRY; VIRUS INHIBITION; VIRUS LOAD; VIRUS STRAIN; CELL LINE; CHEMISTRY; DRUG EFFECTS; HELA CELL LINE; HUMAN; METABOLISM; TUMOR CELL LINE;

ANTI-HIV AGENTS; CELL LINE; CELL LINE, TUMOR; CHITOSAN; HELA CELLS; HIV-1; HUMANS; PEPTIDE HYDROLASES; PEPTIDES; RNA-DIRECTED DNA POLYMERASE; VIRAL LOAD;

EID: 84900362286     PISSN: 01418130     EISSN: 18790003     Source Type: Journal    
DOI: 10.1016/j.ijbiomac.2014.02.020     Document Type: Article

References (23)

1. UNAIDS AIDS Epidemic Update 2012, UNAIDS, http://www.unaids.org.
2. Stoddart C.A., Reyes R.A. Drug Discovery Today: Dis. Models 2007, 1:113-119.
3. Tziveleka L.A., Vagias C., Roussis V. Curr. Top. Med. Chem. 2003, 13:1512-1535.
4. Sing I.P., Bharate S.B., Bhutani K.K. Curr. Sci. (Bang.) 2003, 89:269-290.
5. Schaeffer D.J., Krylov V.S. Ecotoxicol. Environ. Saf. 2000, 45:208-227.
6. Fenton J.I., Chlebek-Brown K.A., Peters T.L., Caron J.P., Orth M.W. Osteoarthritis Cartilage 2000, 6:444-541.
7. Nagahama H., Nwe N., Jayakumar R., Koiwa S., Furuike T., Tamura H. Carbohydr. Polym. 2008, 73:295-302.
8. Jayakumar R., Prabaharan M., Nair S.V., Tamura H. Biotechnol. Adv. 2010, 28:142-150.
9. Muzzarelli R.A.A., Muzzarelli C. Adv. Polym. Sci. 2005, 186:151-209.
10. Rinaudo M. Prog. Polym. Sci. 2006, 31:603-632.
11. Mourya V.K., Inamdar N.N. React. Funct. Polym. 2008, 68:1013-1051.
12. Zheng Y.T., Zhang W.F., Ben K.L., Wang J.H. Immunopharmacol. Immunotoxicol. 1995, 17:69-79.
13. Zheng Y.T., Ben K.L., Jin S.W. Acta Pharmacol. Sin. 2000, 21:179-182.
14. Chun T.W., Nickle D.C., Justement J.S., Meyers J.H., Roby G., Hallahan C.W., Kottilil S., Moir S., Mican J.M., Mullins J.L., Ward D.J., Kovacs J.A., Mannon P.J., Fauci A.S. J. Infect. Dis. 2008, 197:714-720.
15. Fauci A.S. Nature 1996, 384:529-534.
16. Lee D.S., Jung K.E., Yoon C.H., Lim H., Bae Y.S. Antimicrob. Agents Chemother. 2005, 49:4110-4120.
17. Derdeyn C.A., Decker J.M., Sfakianos J.N., Wu X., O'Brien W.A., Kappes J.C., Rather L., Shaw G.M., Hunter E. J. Virol. 2000, 74:8358-8367.
18. Freed E.O. Virology 1998, 251:1-15.
19. Wilk T., Fuller S.D. Curr. Opin. Struct. Biol. 1999, 9:231-243.
20. Janvier B., Mallet F., Cheynet V., Dalbon P., Vernet G., Besnier J.M., Choutet P., Goudeau A., Mandrand B., Barin F. J. Acquir. Immune Defic. Syndr. 1993, 8:898-903.
21. Haqqani A.A., Tilton J.C. Antiviral Res. 2013, 98:158-170.
22. Stanley B.J., Ehrlich E.S., Short L., Yu Y., Xiao Z., Yu X., Xiong Y. J. Virol. 2008, 82:8656-8663.
23. Chong H., Yao X., Qui Z., Quin B., Han R., Waltersperger S., Wang M., Cui S., He Y. J. Biol. Chem. 2012, 287:20281-20289.